Cannabis for high blood pressure: CBD lowers, THC increases briefly

Cannabis and high blood pressure: Contrasting effects of CBD and THC

Hypertension (high blood pressure) is the most common chronic disease in Germany – over 30 million people are affected. Cannabis consists of cannabinoids with opposite cardiovascular effects: CBD lowers blood pressure, THC increases it in the short term. Understanding this dichotomy is crucial for safe use.

CBD and blood pressure: mechanisms and studies

CBD lowers blood pressure in several ways:

Vasodilation: CBD activates TRPV1 and GPR55 on vascular smooth muscle cells → relaxation of arterial walls → blood pressure reduction. CBD also inhibits the release of noradrenaline from sympathetic nerve endings, which reduces vasoconstriction.

Anxiolysis → Blood pressure reduction: Stress-induced hypertension is a significant proportion of the overall stress. CBD attenuates sympathetic overactivation (cortisol, adrenaline) via 5-HT1A and CB1 modulation.

THC and blood pressure: the biphasic profile

THC has a complex, dose-dependent effect on blood pressure:

Acute (first 10-30 minutes): THC increases heart rate (+20-100 BPM) via sympathetic activation. Simultaneous initial vasodilation → brief drop in blood pressure, followed by reflex increase in heart rate. With change of standing position (orthostasis): THC increases risk of hypotension → dizziness, fainting.

After 30-90 minutes: Reflex tachycardia can increase blood pressure in the case of pre-existing high blood pressure, as the heart performs better (Stokes-Adams dynamics).

Chronic (long-term smokers): Epidemiologically, elevated blood pressure values are found in high users after years – possible mechanisms: sympathetic overactivation during CB1 desensitization, smoking damage.

Patients at risk: Who needs to be particularly careful

Hypertension + antihypertensives: CBD can cause antihypertensives (ACE inhibitors, sartans, calcium antagonists, beta blockers) to cause additive blood pressure reduction → hypotension, dizziness, falls. Self-measurement of blood pressure mandatory on introduction.

Interactions via CYP450:
– Amlodipn (CYP3A4): CBD inhibits → increased amlodipine levels → stronger blood pressure reduction
– Metoprolol (CYP2D6): CBD inhibition → increased metoprolol levels → risk of bradycardia
– Lisinopril/ramipril: no direct CYP interaction, but additive hypotension possible

Isolated systolic hypertension (elderly patients): THC-induced tachycardia increases cardiac risk → avoid THC in cardiac patients.

Cannabis as a hypertension therapy: realistic conclusion

CBD can lower blood pressure in higher doses (150-300 mg daily) – but not as a substitute for proven antihypertensives. Reasons:
1. study size still too small for guideline recommendation
2. optimal dose unclear
3. CYP interactions with existing drugs are difficult to calculate
4. lack of long-term data

Cannabis as a supplement for hypertension that is stress-related and addresses the primary cause of hypertension in anxiolysis is a plausible approach – under medical supervision.

GKV and hypertension

Uncomplicated hypertension alone is not a recognized cannabis indication. In the case of comorbidities (chronic pain, anxiety disorders, sleep disorders) that contribute to hypertension, cannabis may be available on prescription and thus reimbursed by statutory health insurance.

FAQ: Cannabis and high blood pressure

Summary

CBD lowers blood pressure via vasodilation and anxiolysis – Walsh 2021 shows significant effect at 300 mg daily. THC acutely increases heart rate and can cause risks in cardiac patients. CYP interactions with antihypertensives (amlodipine, metoprolol) require monitoring. CBD as a supplement for stress-related hypertension is plausible – not yet in line with guidelines as an antihypertensive substitute. Always discuss interactions with your doctor.